Depression and diabetes distress in patients with diabetes

Kaci Boehmer; Mrinmayee Lakkad; Chris Johnson; Jacob T Painter

doi:10.1016/j.pcd.2022.11.003

Depression and diabetes distress in patients with diabetes

Prim Care Diabetes. 2023 Feb;17(1):105-108. doi: 10.1016/j.pcd.2022.11.003. Epub 2022 Nov 21.

Authors

Kaci Boehmer¹, Mrinmayee Lakkad², Chris Johnson³, Jacob T Painter⁴

Affiliations

¹ University of Arkansas for Medical Sciences College of Pharmacy, Department of Pharmacy Practice, 4301 W. Markham St., Little Rock, AR 72211, USA. Electronic address: kaboehmer@uams.edu.
² University of Arkansas for Medical Sciences, Division of Pharmaceutical Evaluation and Policy, 4301 W. Markham St., Little Rock, AR, USA. Electronic address: mlakkad@uams.edu.
³ University of Arkansas for Medical Sciences College of Pharmacy, Department of Pharmacy Practice, 4301 W. Markham St., Little Rock, AR 72211, USA. Electronic address: cjohnson4@uams.edu.
⁴ University of Arkansas for Medical Sciences, Division of Pharmaceutical Evaluation and Policy, 4301 W. Markham St., Little Rock, AR, USA. Electronic address: jtpainter@uams.edu.

PMID: 36424309
DOI: 10.1016/j.pcd.2022.11.003

Abstract

We aimed to identify the prevalence of comorbid depression, diabetes, and diabetes distress and assess glycemic control and rates of diabetes-related complications. While the presence of either depression or distress did not predict the level of glycemic control, certain macro- and microvascular complications were more prevalent with depression.

Keywords: Complications; Depression; Diabetes; Diabetes distress; Glycemic control.

MeSH terms

Depression / diagnosis
Depression / epidemiology
Diabetes Mellitus, Type 2* / diagnosis
Diabetes Mellitus, Type 2* / drug therapy
Diabetes Mellitus, Type 2* / epidemiology
Humans
Prevalence